Stepan delivered a 5% increase in Q4 net sales to $553.9 million, driven by higher selling prices and favorable mix, despite a 3% decline in global sales volume. While reported net income grew 49%, adjusted net income fell to a loss of $0.5 million due to higher interest expenses and lower Surfactant earnings. The company announced 'Project Catalyst' to optimize its footprint and target $100 million in pre-tax savings over two years.

Stepan Company reported a significant 54% decrease in net income to $10.8 million for Q3 2025, primarily due to a higher effective tax rate and increased interest expense. However, adjusted EBITDA saw a 6% increase to $56.2 million, and free cash flow improved to $40.2 million, driven by working capital reduction. Sales volume increased by 1% year-over-year.

Stepan Company reported a strong second quarter in 2025, with net income increasing by 19% to $11.3 million and adjusted net income rising by 27% to $12.0 million. This growth was primarily fueled by improved results in the Polymers segment and the Crop Productivity business, coupled with a favorable effective tax rate. Adjusted EBITDA also saw an 8% increase year-over-year, reaching $51.4 million, despite higher start-up costs at the new Pasadena alkoxylation site and increased oleochemical raw material costs.

Stepan Company reported a strong start to 2025 with significant increases in net income and operating income, driven by volume growth across its Surfactants, Polymers, and Specialty Products segments. Despite negative free cash flow due to working capital investments, the company remains cautiously optimistic for full-year growth and positive free cash flow.

Stepan Company reported a net income of $3.4 million, a significant increase compared to the prior year's net loss of $1.2 million. However, adjusted net income decreased by 63% to $2.8 million due to higher pre-commissioning expenses, a one-time tax proceeding reserve, and CEO transition costs. Cash from operations was $68.3 million, and free cash flow was $32.1 million. The company delivered $13.0 million in pre-tax cost out savings.

Stepan Company reported an 88% increase in net income and an 11% increase in adjusted EBITDA for the third quarter of 2024. The growth was primarily driven by the Surfactant and Specialty Product businesses, with Surfactants experiencing double-digit volume growth in several end markets. However, Polymer volumes declined due to soft demand and competitive pressures. The company is on track to deliver its $50 million cost out goal for 2024, with $13.3 million in pre-tax savings recognized in the third quarter.

Stepan Company's second quarter earnings were negatively impacted by higher operational expenses at the Millsdale site, start-up costs for the Pasadena investment, and a criminal fraud event in Asia. Despite these challenges, the company saw volume growth in several core markets and delivered adjusted EBITDA growth of 4%.

Stepan Company reported a decrease in net income but an increase in adjusted EBITDA for Q1 2024. The company is on track to deliver its $50 million cost out goal for the year and recognized $18 million in pre-tax savings in the first quarter. Global sales volume was up 1%, and cash from operations was $41.6 million.

Stepan Company reported a net loss of $1.2 million for Q4 2023, compared to a net income of $10.8 million in the prior year. Adjusted net income was $7.5 million, versus $13.5 million in the prior year. Total company sales volume increased 3% year-over-year, driven by double-digit growth in Rigid Polyols volumes. The company expects $50 million in pre-tax cost savings in 2024.

Stepan Company reported a decrease in net income for Q3 2023, with $12.6 million compared to $39.4 million in the prior year. The decline was influenced by lower sales volume and unit margins in the Surfactant and Specialty Product segments. However, there was sequential growth versus the second quarter of 2023, led by higher Rigid Polyols demand and new contracted volume for low 1,4 dioxane products.

Stepan Company reported a decrease in net income and earnings per share for Q2 2023 compared to the prior year, primarily due to a 19% reduction in sales volume. The decline was attributed to lower demand, customer destocking, and backward integration by a customer. The company is implementing cost control and cash management initiatives to address the challenging environment.

Stepan Company reported a decrease in net income and sales volume for Q1 2023 compared to the prior year. Net income was $16.1 million, or $0.70 per diluted share, versus $44.8 million, or $1.93 per diluted share in the prior year. Total Company sales volume decreased 14% versus the prior year.

Stepan Company reported a decrease in net income for the fourth quarter of 2022, primarily due to lower sales volumes in the Surfactant and Polymer segments, partially offset by improved performance in the Specialty Products segment. Customer destocking and lower demand in certain markets contributed to the decline. Full year earnings reached a record high.

Stepan Company reported a record net income of $39.4 million, or $1.71 per diluted share, for the third quarter of 2022, compared to $36.9 million, or $1.59 per diluted share, in the prior year. Adjusted net income was $46.3 million, or $2.01 per diluted share, versus $36.4 million, or $1.57 per diluted share, in the prior year. Total Company sales volume decreased 8% versus the prior year.

Stepan Company reported a record second quarter with net income reaching $52.1 million, or $2.26 per diluted share, compared to $43.3 million, or $1.85 per diluted share, in the previous year. Adjusted net income was a record $53.0 million, or $2.30 per diluted share, versus $42.2 million, or $1.81 per diluted share, in the prior year. The company experienced a slight decline in total sales volume by 1% year-over-year, but this was offset by higher selling prices and improved product mix.

Stepan Company reported a solid start to the year with a 26% increase in net sales and a 10% increase in net income compared to the prior year. The company faced challenges including a power outage at the Millsdale, IL plant and ongoing global supply chain issues, but saw growth in surfactant operating income and polymer sales volume.

Stepan Company's fourth quarter net income decreased by 44% to $17.0 million, or $0.73 per diluted share, compared to the prior year. Adjusted net income decreased by 32% to $22.5 million, or $0.97 per diluted share. Total Company sales volume decreased 4% versus the prior year. The results were impacted by supply chain disruptions and the non-recurrence of a $13.0 million insurance recovery from the prior year.

Stepan Company reported an 11% increase in net income to $36.9 million, or $1.59 per diluted share, compared to $33.2 million, or $1.43 per diluted share, in the prior year. Total Company sales volume increased 1% versus the prior year. However, surfactant operating income decreased due to supply chain disruptions and lower sales volume, while polymer operating income was also down due to supply chain issues and non-recurring events from the previous year.

Stepan Company reported a record second quarter with net income of $43.3 million, or $1.85 per diluted share, compared to $35.7 million, or $1.54 per diluted share, in the prior year. Adjusted net income was $42.2 million, or $1.81 per diluted share, versus $38.3 million, or $1.65 per diluted share, in the prior year. Total Company sales volume increased 5% year-over-year, with significant growth in the Polymer segment offsetting a decrease in Surfactant sales volume.

Stepan Company reported record net income of $40.6 million, or $1.74 per diluted share, and adjusted net income of $42.4 million, or $1.82 per diluted share. Total Company sales volume increased 6% versus the prior year. The company exceeded $1 billion of equity for the first time.

Stepan Company reported a strong fourth quarter with net income reaching $30.4 million, or $1.30 per diluted share, compared to $22.0 million, or $0.95 per diluted share, in the prior year. Adjusted net income was $33.1 million, or $1.42 per diluted share, versus $25.7 million, or $1.10 per diluted share, in the prior year. The company's performance was driven by increased demand for cleaning and disinfection products and an insurance recovery related to a plant power outage.

Stepan Company reported a strong third quarter with net income increasing to $33.2 million, or $1.43 per diluted share, compared to $25.9 million, or $1.11 per diluted share, in the prior year. Adjusted net income was $36.4 million, or $1.56 per diluted share, a 30% increase. The Surfactant segment saw significant operating income growth due to increased sales volume, while the Polymer segment experienced a slight decline. The company's strong balance sheet and cash position support future growth.

Stepan Company reported record net income for the second quarter of 2020, driven by strong surfactant sales volume growth due to increased demand for cleaning and disinfection products. However, the polymer business was down due to construction project delays, and the specialty product business was affected by order timing and margin issues.

Stepan Company reported a net income of $27.5 million, or $1.18 per diluted share, compared to $25.0 million, or $1.07 per diluted share, in the prior year. However, adjusted net income was $24.2 million, or $1.04 per diluted share, versus $30.6 million, or $1.31 per diluted share, in the prior year, impacted by a power outage at the Millsdale Plant. Surfactant operating income was $36.2 million, while Polymer operating income was $7.5 million, and Specialty Product operating income was $4.0 million.

Stepan Company reported a decrease in net income but an increase in adjusted net income for Q4 2019. Surfactant earnings improved due to insurance recovery and margin improvements, while the Polymer business benefited from rigid polyol growth. Specialty Products income saw a slight decrease due to order timing.